Challenges to pediatric HIV care and treatment in South Africa.
about
Institutionalizing provider-initiated HIV testing and counselling for children: an observational case study from ZambiaLessons learned from family-centred models of treatment for children living with HIV: current approaches and future directionsART access-related barriers faced by HIV-positive persons linked to care in southern Ghana: a mixed method studyPregnant women's access to PMTCT and ART services in South Africa and implications for universal antiretroviral treatment.Need for timely paediatric HIV treatment within primary health care in rural South Africa.Effect of provider-initiated testing and counselling and integration of ART services on access to HIV diagnosis and treatment for children in Lilongwe, Malawi: a pre- post comparison.HIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation.Challenges for rapid molecular HIV diagnostics.The association between quality of HIV care, loss to follow-up and mortality in pediatric and adolescent patients receiving antiretroviral therapy in NigeriaOutcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration.Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa.Effects of leisure activities and psychosocial support on medication adherence and clinic attendance among children on antiretroviral therapy.Paediatric antiretroviral treatment programmes in sub-Saharan Africa: a review of published clinical studiesIncreased vulnerability of rural children on antiretroviral therapy attending public health facilities in South Africa: a retrospective cohort studyIncreases in pediatric antiretroviral treatment, South Africa 2005-2010.Pediatric response to second-line antiretroviral therapy in South AfricaRetention in care of HIV-infected children from HIV test to start of antiretroviral therapy: systematic review.Access to HIV prevention and care for HIV-exposed and HIV-infected children: a qualitative study in rural and urban Mozambique.Morbidity and mortality among infants born to HIV-infected women in South Africa: implications for child health in resource-limited settings.Temporal trends in the characteristics of children at antiretroviral therapy initiation in southern Africa: the IeDEA-SA CollaborationRealities and Challenges of a Five Year Follow Up of Mother and Child Pairs on a PMTCT Program in Zimbabwe.Rapid development of antiretroviral drug resistance mutations in HIV-infected children less than two years of age initiating protease inhibitor-based therapy in South Africa.Successful paediatric HIV treatment in rural primary care in Africa.Challenges faced by elderly guardians in sustaining the adherence to antiretroviral therapy in HIV-infected children in Zimbabwe.The burden of disease on HIV-infected orphaned and non-orphaned children accessing primary health facilities in a rural district with poor resources in South Africa: a cross-sectional survey of primary caregivers of HIV-infected children aged 5-18 yAdapting Evidence-Based Interventions to Meet the Needs of Adolescents Growing Up with HIV in South Africa: The VUKA Case Example.Disclosure, stigma of HIV positive child and access to early infant diagnosis in the rural communities of OR Tambo District, South Africa: a qualitative exploration of maternal perspective.Child mortality levels and trends by HIV status in Blantyre, Malawi: 1989-2009.Disclosure of their HIV status to infected children: a review of the literature.Translation of biomedical prevention strategies for HIV: prospects and pitfalls."It's my secret": barriers to paediatric HIV treatment in a poor rural South African setting.Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS."Making it personal": ideology, the arts, and shifting registers in health promotion.Human Immunodeficiency Virus-1 Sequence Changes and Drug Resistance Mutation Among Virologic Failures of Lopinavir/Ritonavir Monotherapy: AIDS Clinical Trials Group Protocol A5230.Insights into Adherence among a Cohort of Adolescents Aged 12-20 Years in South Africa: Reported Barriers to Antiretroviral Treatment.The acceptability and feasibility of routine pediatric HIV testing in an outpatient clinic in Durban, South AfricaDrug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort.Factors affecting adherence to short-course ARV prophylaxis for preventing mother-to-child transmission of HIV in sub-Saharan Africa: a review and lessons for future elimination.Promoting uptake of child HIV testing: an evaluation of the role of a home visiting program for orphans and vulnerable children in South Africa.Cohort Profile: The Khayelitsha antiretroviral programme, Cape Town, South Africa.
P2860
Q28730437-8DCAF5AB-470A-487A-9140-6D774B1352A6Q30495089-475AB8E4-21C7-45AC-8DED-042361461E77Q30831066-576FC2E7-2D32-4650-BF2C-FCA5011858B7Q31043326-21278FE4-3D8D-4BED-9A12-69347189B0CAQ33505672-C3305B2F-8EB0-4FF5-8E92-FF5E840BD252Q33519698-63D39925-27C6-4042-A7E6-CB09E0D04683Q33647438-14D92A97-D1F1-4E2B-B6FE-6A5F95D83ADCQ33736782-6C355FE4-92EA-4598-B51C-7C5AAAE1E93AQ33974971-D9B1281C-1ACB-422F-8049-947C5DF86217Q34077658-7ECD46B5-E369-48FD-939F-E258035E8474Q34077664-303BC00B-7444-4FEB-A9AD-62E22D659C3CQ34139870-0761E3E3-969A-4A35-960A-0F06C7925905Q34358076-A3151ED3-EA33-4FB9-BCEE-98ED9FBAAB62Q34408061-302527F6-0C14-4A74-90A6-674BC162728BQ34427645-0289C484-AB4F-4953-99B6-8151ED3233E4Q34490216-D37C8D98-1C27-4144-BA30-1EF44D1DB0FFQ34598728-38D14C1D-4ED8-46F4-B4F1-5C8A88566852Q34695141-9C02A08F-00E7-43F2-908E-2B1664EBF922Q35022515-2C68F168-C143-464E-87B7-EF0AE6F8AB88Q35074354-079F3FEB-3CCB-4709-A526-2F3CF10C6FB6Q35101274-61290ADE-B4D2-4967-B056-94F7141DB661Q35179391-D086F2DD-E9ED-45B4-BE2A-E62B5801A201Q35235913-EF2371D3-060E-4FA4-BACF-786CEEE1EA89Q35507786-895B60D6-CDE4-4F81-85A2-16E1D50238BCQ35580318-C569BD08-D251-4633-981E-CE9361DB658AQ35606329-10C34C13-FD93-4800-B28F-62FCC202A882Q35755070-07CDEC61-A4C2-42C8-8307-9904BF29FD54Q36279151-5AC2BFB4-148E-4474-8839-8819902C47F6Q36956992-693AC181-DDA6-4037-9C3C-A3A91C64FF96Q37051717-E32A8633-7A49-4FCF-A06D-977CE2B88C77Q37130566-18ADDB5D-2AA5-4F44-8681-4254B4A6FB20Q37182021-F25486BB-64AC-4EB6-A7D8-899FA4FF5841Q37189623-096AF29D-59D5-480C-848C-0950F9123B80Q37305622-E9CA475C-57A7-4152-88B4-62E08FB4CBB9Q37404721-3DA6C28D-78E4-4843-B27F-2B693CB67951Q37491145-895EB9AE-C64C-4EE4-B062-B9A271F7E5BFQ37580891-532571A6-55F6-45C7-8212-BC9F85452CB3Q38172614-22E175CB-351B-4BD9-BCE4-1B226F5FFFFBQ39523601-6ABCD469-F69E-40D9-9A6C-2894112E0BD2Q40665399-FB8335F4-FCD9-4AA2-BB82-2DDF0C49D271
P2860
Challenges to pediatric HIV care and treatment in South Africa.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Challenges to pediatric HIV care and treatment in South Africa.
@en
Challenges to pediatric HIV care and treatment in South Africa.
@nl
type
label
Challenges to pediatric HIV care and treatment in South Africa.
@en
Challenges to pediatric HIV care and treatment in South Africa.
@nl
prefLabel
Challenges to pediatric HIV care and treatment in South Africa.
@en
Challenges to pediatric HIV care and treatment in South Africa.
@nl
P2093
P2860
P356
P1476
Challenges to pediatric HIV care and treatment in South Africa.
@en
P2093
Brian Eley
Gayle Sherman
Kimesh Naidoo
Mark Cotton
Tammy Meyers
P2860
P304
P356
10.1086/521116
P407
P478
196 Suppl 3
P577
2007-12-01T00:00:00Z